Clinical Trial Update: Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating abatacept for lupus nephritis was terminated; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Lupus Nephritis | Phase 3 | Status: TERMINATED | Results posted: 2017-12-21